BRUKER CORPORATION Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
BRUKER CORPORATION (BRKR) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 400.00 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-02-27
- BRUKER CORPORATION antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 1.30M shares, a 333.33% increase year-over-year.
- BRUKER CORPORATION antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-09-30 was 300.00K shares.
- BRUKER CORPORATION antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 400.00K shares, a 33.33% increase from fiscal 2024.
- BRUKER CORPORATION antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 300.00K shares, a 50.00% increase from fiscal 2023.
- BRUKER CORPORATION antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 200.00K shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|
| 2025-12-31 | 400.00K shares 10-K · filed 2026-02-27 | ||
| 2025-09-30 | 1.30M shares 10-Q · filed 2025-11-05 | 1.30M shares 10-Q · filed 2025-11-05 | |
| 2024-12-31 | 300.00K shares 10-K · filed 2026-02-27 | ||
| 2024-09-30 | 300.00K shares 10-Q · filed 2025-11-05 | 300.00K shares 10-Q · filed 2025-11-05 | |
| 2023-12-31 | 200.00K shares 10-K · filed 2026-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |